1.Neal, B.; Wu, J. Sodium, blood pressure, and the likely massive avoidable burden of cardiovascular disease. Circulation. 2021, 143, 1568-1570.
2. Ruan, Y.; Guo, Y.; Zheng, Y.; Huang, Z.; Sun, S.; Kowal, P.; Shi, Y.; Wu, F. Cardiovascular disease (CVD) and associated risk factors among older adults in six low-and middle-income countries: results from SAGE Wave 1. BMC Public Health. 2018, 18, 778.
3. Cahill, T. J.; Ashrafian, H.; Watkins, H. Genetic cardiomyopathies causing heart failure. Circ Res. 2013, 113, 660-675.
4. Elliott, P.; Andersson, B.; Arbustini, E.; Bilinska, Z.; Cecchi, F.; Charron, P.; Dubourg, O.; Kühl, U.; Maisch, B.; McKenna, W. J.; Monserrat, L.; Pankuweit, S.; Rapezzi, C.; Seferovic, P.; Tavazzi, L.; Keren, A. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008, 29, 270-276.
5. Franz, W. M.; Müller, O. J.; Katus, H. A. Cardiomyopathies: from genetics to the prospect of treatment. Lancet. 2001, 358, 1627-1637.
6. Kimura, A. Molecular genetics and pathogenesis of cardiomyopathy. J Hum Genet. 2016, 61, 41-50.
7. Zhou, J.; Su, J.; Fu, X.; Zheng, L.; Yin, Z. Microfluidic device for primary tumor spheroid isolation. Exp Hematol Oncol. 2017, 6, 22.
8. Ben-David, U.; Ha, G.; Tseng, Y. Y.; Greenwald, N. F.; Oh, C.; Shih, J.; McFarland, J. M.; Wong, B.; Boehm, J. S.; Beroukhim, R.; Golub, T. R. Patient-derived xenografts undergo mouse-specific tumor evolution. Nat Genet. 2017, 49, 1567-1575.
9. Wu, Y.; Qin, M.; Yang, X. Organ bioprinting: progress, challenges and outlook. J Mater Chem B. 2023, 11, 10263-10287.
10. Zhu, L.; Liu, K.; Feng, Q.; Liao, Y. Cardiac organoids: a 3D technology for modeling heart development and disease. Stem Cell Rev Rep. 2022, 18, 2593-2605.
11. Miyamoto, M.; Nam, L.; Kannan, S.; Kwon, C. Heart organoids and tissue models for modeling development and disease. Semin Cell Dev Biol. 2021, 118, 119-128.
12. Lewis-Israeli, Y. R.; Wasserman, A. H.; Aguirre, A. Heart organoids and engineered heart tissues: novel tools for modeling human cardiac biology and disease. Biomolecules. 2021, 11, 1277.
13. Xu, H.; Jiao, Y.; Qin, S.; Zhao, W.; Chu, Q.; Wu, K. Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicine. Exp Hematol Oncol. 2018, 7, 30.
14. Cho, J.; Lee, H.; Rah, W.; Chang, H. J.; Yoon, Y. S. From engineered heart tissue to cardiac organoid. Theranostics. 2022, 12, 2758-2772.
15. Jaconi, M. E.; Puceat, M. Cardiac organoids and gastruloids to study physio-pathological heart development. J Cardiovasc Dev Dis. 2021, 8, 178.
16. Lee, S. G.; Kim, Y. J.; Son, M. Y.; Oh, M. S.; Kim, J.; Ryu, B.; Kang, K. R.; Baek, J.; Chung, G.; Woo, D. H.; Kim, C. Y.; Chung, H. M. Generation of human iPSCs derived heart organoids structurally and functionally similar to heart. Biomaterials. 2022, 290, 121860.
17. Rossi, G.; Manfrin, A.; Lutolf, M. P. Progress and potential in organoid research. Nat Rev Genet. 2018, 19, 671-687.
18. Lancaster, M. A.; Knoblich, J. A. Organogenesis in a dish: modeling development and disease using organoid technologies. Science. 2014, 345, 1247125.
19. Saorin, G.; Caligiuri, I.; Rizzolio, F. Microfluidic organoids-on-a-chip: The future of human models. Semin Cell Dev Biol. 2023, 144, 41-54.
20. Jiang, S.; Feng, W.; Chang, C.; Li, G. Modeling human heart development and congenital defects using organoids: how close are we? J Cardiovasc Dev Dis. 2022, 9, 125.
21. Schmidt, C.; Deyett, A.; Ilmer, T.; Haendeler, S.; Torres Caballero, A.; Novatchkova, M.; Netzer, M. A.; Ceci Ginistrelli, L.; Mancheno Juncosa, E.; Bhattacharya, T.; Mujadzic, A.; Pimpale, L.; Jahnel, S. M.; Cirigliano, M.; Reumann, D.; Tavernini, K.; Papai, N.; Hering, S.; Hofbauer, P.; Mendjan, S. Multi-chamber cardioids unravel human heart development and cardiac defects. Cell. 2023, 186, 5587-5605.e27.
22. Ng, W. H.; Varghese, B.; Jia, H.; Ren, X. Alliance of heart and endoderm: multilineage organoids to model co-development. Circ Res. 2023, 132, 511-518.
23. Tang, X. Y.; Wu, S.; Wang, D.; Chu, C.; Hong, Y.; Tao, M.; Hu, H.; Xu, M.; Guo, X.; Liu, Y. Human organoids in basic research and clinical applications. Signal Transduct Target Ther. 2022, 7, 168.
24. Kannankeril, P. J.; Roden, D. M. Drug-induced long QT and torsade de pointes: recent advances. Curr Opin Cardiol. 2007, 22, 39-43.
25. Tang, C. P. S.; McMullen, J.; Tam, C. Cardiac side effects of bruton tyrosine kinase (BTK) inhibitors. Leuk Lymphoma. 2018, 59, 1554-1564.
26. Burridge, P. W.; Li, Y. F.; Matsa, E.; Wu, H.; Ong, S. G.; Sharma, A.; Holmström, A.; Chang, A. C.; Coronado, M. J.; Ebert, A. D.; Knowles, J. W.; Telli, M. L.; Witteles, R. M.; Blau, H. M.; Bernstein, D.; Altman, R. B.; Wu, J. C. Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity. Nat Med. 2016, 22, 547-556.
27. Woosley, R. L. Cardiac actions of antihistamines. Annu Rev Pharmacol Toxicol. 1996, 36, 233-252.
28. Glassman, A. H.; Bigger, J. T., Jr. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry. 2001, 158, 1774-1782.
29. Johnson, R. A.; Palacios, I. Dilated cardiomyopathies of the adult (second of two parts). N Engl J Med. 1982, 307, 1119 - 1126.
30. Gintant, G. A.; Limberis, J. T.; McDermott, J. S.; Wegner, C. D.; Cox, B. F. The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug - induced arrhythmogenesis. J Cardiovasc Pharmacol. 2001, 37, 607 - 618.
31. Kramer, J.; Obejero - Paz, C. A.; Myatt, G.; Kuryshev, Y. A.; Bruening - Wright, A.; Verducci, J. S.; Brown, A. M. MICE models: superior to the HERG model in predicting Torsade de Pointes. Sci Rep. 2013, 3, 2100.
32. Smith, A. S.; Macadangdang, J.; Leung, W.; Laflamme, M. A.; Kim, D. H. Human iPSC - derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening. Biotechnol Adv. 2017, 35, 77 - 94.
33. Pontes Soares, C.; Midlej, V.; de Oliveira, M. E.; Benchimol, M.; Costa, M. L.; Mermelstein, C. 2D and 3D - organized cardiac cells shows differences in cellular morphology, adhesion junctions, presence of myofibrils and protein expression. PLoS One. 2012, 7, e38147.
34. Abbott, A. Cell culture: biology’s new dimension. Nature. 2003, 424, 870 - 872.
35. Uzun, A. U.; Mannhardt, I.; Breckwoldt, K.; Horváth, A.; Johannsen, S. S.; Hansen, A.; Eschenhagen, T.; Christ, T. Ca(2 + ) - currents in human induced pluripotent stem cell - derived cardiomyocytes effects of two different culture conditions. Front Pharmacol. 2016, 7, 300.
36. Mannhardt, I.; Breckwoldt, K.; Letuffe - Brenière, D.; Schaaf, S.; Schulz, H.; Neuber, C.; Benzin, A.; Werner, T.; Eder, A.; Schulze, T.; Klampe, B.; Christ, T.; Hirt, M. N.; Huebner, N.; Moretti, A.; Eschenhagen, T.; Hansen, A. Human engineered heart tissue: analysis of contractile force. Stem Cell Reports. 2016, 7, 29 - 42.
37. Li, Y.; Huang, G.; Li, M.; Wang, L.; Elson, E. L.; Lu, T. J.; Genin, G. M.; Xu, F. An approach to quantifying 3D responses of cells to extreme strain. Sci Rep. 2016, 6, 19550.
38. Li, C. L.; Tian, T.; Nan, K. J.; Zhao, N.; Guo, Y. H.; Cui, J.; Wang, J.; Zhang, W. G. Survival advantages of multicellular spheroids vs. monolayers of HepG2 cells in vitro. Oncol Rep. 2008, 20, 1465 - 1471.
39. Zhang, W.; Chen, Y.; Li, M.; Cao, S.; Wang, N.; Zhang, Y.; Wang, Y. A PDA - functionalized 3D lung scaffold bioplatform to construct complicated breast tumor microenvironment for anticancer drug screening and immunotherapy. Adv Sci (Weinh). 2023, 10, e2302855.
40. Hoang, P.; Sun, S.; Tarris, B. A.; Ma, Z. Controlling morphology and functions of cardiac organoids by two - dimensional geometrical templates. Cells Tissues Organs. 2023, 212, 64 - 73.
41. Noël, E. S. Cardiac construction - Recent advances in morphological and transcriptional modeling of early heart development. Curr Top Dev Biol. 2024, 156, 121 - 156.
42. Domian, I. J.; Chiravuri, M.; van der Meer, P.; Feinberg, A. W.; Shi, X.; Shao, Y.; Wu, S. M.; Parker, K. K.; Chien, K. R. Generation of functional ventricular heart muscle from mouse ventricular progenitor cells. Science. 2009, 326, 426 - 429.
43. Kattman, S. J.; Witty, A. D.; Gagliardi, M.; Dubois, N. C.; Niapour, M.; Hotta, A.; Ellis, J.; Keller, G. Stage - specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell. 2011, 8, 228 - 240.
44. Correia, C.; Koshkin, A.; Duarte, P.; Hu, D.; Carido, M.; Sebastião, M. J.; Gomes - Alves, P.; Elliott, D. A.; Domian, I. J.; Teixeira, A. P.; Alves, P. M.; Serra, M. 3D aggregate culture improves metabolic maturation of human pluripotent stem cell derived cardiomyocytes. Biotechnol Bioeng. 2018, 115, 630 - 644.
45. Kempf, H.; Kropp, C.; Olmer, R.; Martin, U.; Zweigerdt, R. Cardiac differentiation of human pluripotent stem cells in scalable suspension culture. Nat Protoc. 2015, 10, 1345 - 1361.
46. Eschenhagen, T.; Zimmermann, W. H. Engineering myocardial tissue. Circ Res. 2005, 97, 1220 - 1231.
47. Daly, A. C.; Davidson, M. D.; Burdick, J. A. 3D bioprinting of high cell - density heterogeneous tissue models through spheroid fusion within self - healing hydrogels. Nat Commun. 2021, 12, 753.
48. Lewis - Israeli, Y. R.; Wasserman, A. H.; Gabalski, M. A.; Volmert, B. D.; Ming, Y.; Ball, K. A.; Yang, W.; Zou, J.; Ni, G.; Pajares, N.; Chatzistavrou, X.; Li, W.; Zhou, C.; Aguirre, A. Self - assembling human heart organoids for the modeling of cardiac development and congenital heart disease. Nat Commun. 2021, 12, 5142.
49. Aalders, J.; Léger, L.; Piras, D.; van Hengel, J.; Ledda, S. Use of transparent liquid marble: microbioreactor to culture cardiospheres. Methods Mol Biol. 2021, 2273, 85 - 102.
50. Polonchuk, L.; Chabria, M.; Badi, L.; Hoflack, J. C.; Figtree, G.; Davies, M. J.; Gentile, C. Cardiac spheroids as promising in vitro models to study the human heart microenvironment. Sci Rep. 2017, 7, 7005.
51. Beauchamp, P.; Jackson, C. B.; Ozhathil, L. C.; Agarkova, I.; Galindo, C. L.; Sawyer, D. B.; Suter, T. M.; Zuppinger, C. 3D co - culture of hiPSC - derived cardiomyocytes with cardiac fibroblasts improves tissue - like features of cardiac spheroids. Front Mol Biosci. 2020, 7, 14.
52. Zuppinger, C. Measurement of contractility and calcium release in cardiac spheroids. Methods Mol Biol. 2019, 1929, 41 - 52.
53. Giacomelli, E.; Meraviglia, V.; Campostrini, G.; Cochrane, A.; Cao, X.; van Helden, R. W. J.; Krotenberg Garcia, A.; Mircea, M.; Kostidis, S.; Davis, R. P.; van Meer, B. J.; Jost, C. R.; Koster, A. J.; Mei, H.; Míguez, D. G.; Mulder, A. A.; Ledesma - Terrón, M.; Pompilio, G.; Sala, L.; Salvatori, D. C. F.; Slieker, R. C.; Sommariva, E.; de Vries, A. A. F.; Giera, M.; Semrau, S.; Tertoolen, L. G. J.; Orlova, V. V.; Bellin, M.; Mummery, C. L. Human - iPSC - derived cardiac stromal cells enhance maturation in 3D cardiac microtissues and reveal non - cardiomyocyte contributions to heart disease. Cell Stem Cell. 2020, 26, 862 - 879.e11.
54. Ong, C. S.; Pitaktong, I.; Hibino, N. Principles of spheroid preparation for creation of 3D cardiac tissue using biomaterial - free bioprinting. Methods Mol Biol. 2020, 2140, 183 - 197.
55. Arai, K.; Murata, D.; Verissimo, A. R.; Mukae, Y.; Itoh, M.; Nakamura, A.; Morita, S.; Nakayama, K. Fabrication of scaffold - free tubular cardiac constructs using a Bio - 3D printer. PLoS One. 2018, 13, e0209162.
56. Pinto, A. R.; Ilinykh, A.; Ivey, M. J.; Kuwabara, J. T.; D’Antoni, M. L.; Debuque, R.; Chandran, A.; Wang, L.; Arora, K.; Rosenthal, N. A.; Tallquist, M. D. Revisiting cardiac cellular composition. Circ Res. 2016, 118, 400 - 409.
57. Winbo, A.; Ramanan, S.; Eugster, E.; Jovinge, S.; Skinner, J. R.; Montgomery, J. M. Functional coculture of sympathetic neurons and cardiomyocytes derived from human - induced pluripotent stem cells. Am J Physiol Heart Circ Physiol. 2020, 319, H927 - H937.
58. Devalla, H. D.; Passier, R. Cardiac differentiation of pluripotent stem cells and implications for modeling the heart in health and disease. Sci Transl Med. 2018, 10, eaah5457.
59. Noguchi, R.; Nakayama, K.; Itoh, M.; Kamohara, K.; Furukawa, K.; Oyama, J. I.; Node, K.; Morita, S. Development of a three - dimensional pre - vascularized scaffold - free contractile cardiac patch for treating heart disease. J Heart Lung Transplant. 2016, 35, 137 - 145.
60. Pitaktong, I.; Lui, C.; Lowenthal, J.; Mattson, G.; Jung, W. H.; Bai, Y.; Yeung, E.; Ong, C. S.; Chen, Y.; Gerecht, S.; Hibino, N. Early vascular cells improve microvascularization within 3D cardiac spheroids. Tissue Eng Part C Methods. 2020, 26, 80 - 90.
61. Litviňuková, M.; Talavera - López, C.; Maatz, H.; Reichart, D.; Worth, C. L.; Lindberg, E. L.; Kanda, M.; Polanski, K.; Heinig, M.; Lee, M.; Nadelmann, E. R.; Roberts, K.; Tuck, L.; Fasouli, E. S.; DeLaughter, D. M.; McDonough, B.; Wakimoto, H.; Gorham, J. M.; Samari, S.; Mahbubani, K. T.; Saeb - Parsy, K.; Patone, G.; Boyle, J. J.; Zhang, H.; Zhang, H.; Viveiros, A.; Oudit, G. Y.; Bayraktar, O. A.; Seidman, J. G.; Seidman, C. E.; Noseda, M.; Hubner, N.; Teichmann, S. A. Cells of the adult human heart. Nature. 2020, 588, 466 - 472.
62. Hofbauer, P.; Jahnel, S. M.; Mendjan, S. In vitro models of the human heart. Development. 2021, 148, dev199672.
63. Caspi, O.; Lesman, A.; Basevitch, Y.; Gepstein, A.; Arbel, G.; Habib, I. H.; Gepstein, L.; Levenberg, S. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res. 2007, 100, 263 - 272.
64. Saini, H.; Navaei, A.; Van Putten, A.; Nikkhah, M. 3D cardiac microtissues encapsulated with the co - culture of cardiomyocytes and cardiac fibroblasts. Adv Healthc Mater. 2015, 4, 1961 - 1971.
65. Zhao, Y.; Rafatian, N.; Feric, N. T.; Cox, B. J.; Aschar - Sobbi, R.; Wang, E. Y.; Aggarwal, P.; Zhang, B.; Conant, G.; Ronaldson - Bouchard, K.; Pahnke, A.; Protze, S.; Lee, J. H.; Davenport Huyer, L.; Jekic, D.; Wickeler, A.; Naguib, H. E.; Keller, G. M.; Vunjak - Novakovic, G.; Broeckel, U.; Backx, P. H.; Radisic, M. A platform for generation of chamber - specific cardiac tissues and disease modeling. Cell. 2019, 176, 913 - 927.e8.
66. Oh, Y.; Cho, G. S.; Li, Z.; Hong, I.; Zhu, R.; Kim, M. J.; Kim, Y. J.; Tampakakis, E.; Tung, L.; Huganir, R.; Dong, X.; Kwon, C.; Lee, G. Functional coupling with cardiac muscle promotes maturation of hPSC - derived sympathetic neurons. Cell Stem Cell. 2016, 19, 95 - 106.
67. Schwach, V.; Passier, R. Native cardiac environment and its impact on engineering cardiac tissue. Biomater Sci. 2019, 7, 3566 - 3580.
68. Rienks, M.; Papageorgiou, A. P.; Frangogiannis, N. G.; Heymans, S. Myocardial extracellular matrix: an ever - changing and diverse entity. Circ Res. 2014, 114, 872 - 888.
69. Wang, F.; Zhu, J.; Wang, Y.; Li, J. Recent advances in engineering nanomedicines for second near - infrared photothermal - combinational immunotherapy. Nanomaterials (Basel). 2022, 12, 1656.
70. Wang, F.; Zhu, A.; Zhou, J.; Wang, Y.; Li, J. Near - infrared photoresponsive nanotransducers for precise regulation of gene expression. Bioconjug Chem. 2023. doi: 10.1021/acs.bioconjchem.3c00013.
71. Ariyasinghe, N. R.; Lyra - Leite, D. M.; McCain, M. L. Engineering cardiac microphysiological systems to model pathological extracellular matrix remodeling. Am J Physiol Heart Circ Physiol. 2018, 315, H771 - H789.
72. Cain, B. S.; Meldrum, D. R.; Meng, X.; Shames, B. D.; Banerjee, A.; Harken, A. H. Calcium preconditioning in human myocardium. Ann Thorac Surg. 1998, 65, 1065 - 1070.
73. Kitazawa, T. Effect of extracellular calcium on contractile activation in guinea - pig ventricular muscle. J Physiol. 1984, 355, 635 - 659.
74. Liu, W.; Zhang, X.; Jiang, X.; Dai, B.; Zhang, L.; Zhu, Y. Decellularized extracellular matrix materials for treatment of ischemic cardiomyopathy. Bioact Mater. 2024, 33, 460 - 482.
75. Mills, R. J.; Titmarsh, D. M.; Koenig, X.; Parker, B. L.; Ryall, J. G.; Quaife - Ryan, G. A.; Voges, H. K.; Hodson, M. P.; Ferguson, C.; Drowley, L.; Plowright, A. T.; Needham, E. J.; Wang, Q. D.; Gregorevic, P.; Xin, M.; Thomas, W. G.; Parton, R. G.; Nielsen, L. K.; Launikonis, B. S.; James, D. E.; Elliott, D. A.; Porrello, E. R.; Hudson, J. E. Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest. Proc Natl Acad Sci U S A. 2017, 114, E8372 - E8381.
76. Bowers, S. L. K.; Meng, Q.; Kuwabara, Y.; Huo, J.; Minerath, R.; York, A. J.; Sargent, M. A.; Prasad, V.; Saviola, A. J.; Galindo, D. C.; Hansen, K. C.; Vagnozzi, R. J.; Yutzey, K. E.; Molkentin, J. D. Col1a2 - deleted mice have defective type I collagen and secondary reactive cardiac fibrosis with altered hypertrophic dynamics. Cells. 2023, 12, 2174.
77. Wang, Q.; Yang, H.; Bai, A.; Jiang, W.; Li, X.; Wang, X.; Mao, Y.; Lu, C.; Qian, R.; Guo, F.; Ding, T.; Chen, H.; Chen, S.; Zhang, J.; Liu, C.; Sun, N. Functional engineered human cardiac patches prepared from nature’s platform improve heart function after acute myocardial infarction. Biomaterials. 2016, 105, 52 - 65.
78. Mendibil, U.; Ruiz - Hernandez, R.; Retegi - Carrion, S.; Garcia - Urquia, N.; Olalde - Graells, B.; Abarrategi, A. Tissue - specific decellularization methods: rationale and strategies to achieve regenerative compounds. Int J Mol Sci. 2020, 21, 5447.
79. Bejleri, D.; Davis, M. E. Decellularized extracellular matrix materials for cardiac repair and regeneration. Adv Healthc Mater. 2019, 8, e1801217.
80. Guyette, J. P.; Charest, J. M.; Mills, R. W.; Jank, B. J.; Moser, P. T.; Gilpin, S. E.; Gershlak, J. R.; Okamoto, T.; Gonzalez, G.; Milan, D. J.; Gaudette, G. R.; Ott, H. C. Bioengineering human myocardium on native extracellular matrix. Circ Res. 2016, 118, 56 - 72.
81. Basara, G.; Ozcebe, S. G.; Ellis, B. W.; Zorlutuna, P. Tunable human myocardium derived decellularized extracellular matrix for 3D bioprinting and cardiac tissue engineering. Gels. 2021, 7, 70.
82. Saludas, L.; Pascual - Gil, S.; Prósper, F.; Garbayo, E.; Blanco - Prieto, M. Hydrogel based approaches for cardiac tissue engineering. Int J Pharm. 2017, 523, 454 - 475.
83. Navaee, F.; Khornian, N.; Longet, D.; Heub, S.; Boder - Pasche, S.; Weder, G.; Kleger, A.; Renaud, P.; Braschler, T. A three - dimensional engineered cardiac in vitro model: controlled alignment of cardiomyocytes in 3D microphysiological systems. Cells. 2023, 12, 576.
84. Sharma, D.; Ferguson, M.; Kamp, T. J.; Zhao, F. Constructing biomimetic cardiac tissues: a review of scaffold materials for engineering cardiac patches. Emergent Mater. 2019, 2, 181 - 191.
85. Chachques, J. C.; Trainini, J. C.; Lago, N.; Masoli, O. H.; Barisani, J. L.; Cortes - Morichetti, M.; Schussler, O.; Carpentier, A. Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM clinical trial): one year follow - up. Cell Transplant. 2007, 16, 927 - 934.
86. Kim, B. S.; Kim, H.; Gao, G.; Jang, J.; Cho, D. W. Decellularized extracellular matrix: a step towards the next generation source for bioink manufacturing. Biofabrication. 2017, 9, 034104.
87. Choi, S.; Lee, K. Y.; Kim, S. L.; MacQueen, L. A.; Chang, H.; Zimmerman, J. F.; Jin, Q.; Peters, M. M.; Ardoña, H. A. M.; Liu, X.; Heiler, A. C.; Gabardi, R.; Richardson, C.; Pu, W. T.; Bausch, A. R.; Parker, K. K. Fibre - infused gel scaffolds guide cardiomyocyte alignment in 3D - printed ventricles. Nat Mater. 2023, 22, 1039 - 1046.
88. Zhu, J.; Marchant, R. E. Design properties of hydrogel tissue - engineering scaffolds. Expert Rev Med Devices. 2011, 8, 607 - 626.
89. Shkumatov, A.; Baek, K.; Kong, H. Matrix rigidity - modulated cardiovascular organoid formation from embryoid bodies. PLoS One. 2014, 9, e94764.
90. Navaee, F.; Renaud, P.; Kleger, A.; Braschler, T. Highly efficient cardiac differentiation and maintenance by thrombin - coagulated fibrin hydrogels enriched with decellularized porcine heart extracellular matrix. Int J Mol Sci. 2023, 24, 2842.
91. Asti, A.; Gioglio, L. Natural and synthetic biodegradable polymers: different scaffolds for cell expansion and tissue formation. Int J Artif Organs. 2014, 37, 187 - 205.
92. Navaee, F.; Renaud, P.; Piacentini, N.; Durand, M.; Bayat, D. Z.; Ledroit, D.; Heub, S.; Boder - Pasche, S.; Kleger, A.; Braschler, T.; Weder, G. Toward a physiologically relevant 3D helicoidal - oriented cardiac model: simultaneous application of mechanical stimulation and surface topography. Bioengineering (Basel). 2023, 10, 266.
93. Tallawi, M.; Rosellini, E.; Barbani, N.; Cascone, M. G.; Rai, R.; Saint - Pierre, G.; Boccaccini, A. R. Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review. J R Soc Interface. 2015, 12, 20150254.
94. DePalma, S. J.; Davidson, C. D.; Stis, A. E.; Helms, A. S.; Baker, B. M. Microenvironmental determinants of organized iPSC - cardiomyocyte tissues on synthetic fibrous matrices. Biomater Sci. 2021, 9, 93 - 107.
95. Hendrickson, T.; Mancino, C.; Whitney, L.; Tsao, C.; Rahimi, M.; Taraballi, F. Mimicking cardiac tissue complexity through physical cues: A review on cardiac tissue engineering approaches. Nanomedicine. 2021, 33, 102367.
96. Nunes, S. S.; Miklas, J. W.; Liu, J.; Aschar - Sobbi, R.; Xiao, Y.; Zhang, B.; Jiang, J.; Massé, S.; Gagliardi, M.; Hsieh, A.; Thavandiran, N.; Laflamme, M. A.; Nanthakumar, K.; Gross, G. J.; Backx, P. H.; Keller, G.; Radisic, M. Biowire: a platform for maturation of human pluripotent stem cell - derived cardiomyocytes. Nat Methods. 2013, 10, 781 - 787.
97. Hirt, M. N.; Boeddinghaus, J.; Mitchell, A.; Schaaf, S.; Börnchen, C.; Müller, C.; Schulz, H.; Hubner, N.; Stenzig, J.; Stoehr, A.; Neuber, C.; Eder, A.; Luther, P. K.; Hansen, A.; Eschenhagen, T. Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation. J Mol Cell Cardiol. 2014, 74, 151 - 161.
98. Ruan, J. L.; Tulloch, N. L.; Razumova, M. V.; Saiget, M.; Muskheli, V.; Pabon, L.; Reinecke, H.; Regnier, M.; Murry, C. E. Mechanical stress conditioning and electrical stimulation promote contractility and force maturation of induced pluripotent stem cell - derived human cardiac tissue. Circulation. 2016, 134, 1557 - 1567.
99. Wang, B.; Wang, G.; To, F.; Butler, J. R.; Claude, A.; McLaughlin, R. M.; Williams, L. N.; de Jongh Curry, A. L.; Liao, J. Myocardial scaffold - based cardiac tissue engineering: application of coordinated mechanical and electrical stimulations. Langmuir. 2013, 29, 11109 - 11117.
100. Morgan, K. Y.; Black, L. D., 3rd. Mimicking isovolumic contraction with combined electromechanical stimulation improves the development of engineered cardiac constructs. Tissue Eng Part A. 2014, 20, 1654 - 1667.
101. Unal, A. Z.; West, J. L. Synthetic ECM: bioactive synthetic hydrogels for 3D tissue engineering. Bioconjug Chem. 2020, 31, 2253 - 2271.
102. Moshksayan, K.; Harihara, A.; Mondal, S.; Hegarty, E.; Atherly, T.; Sahoo, D. K.; Jergens, A. E.; Mochel, J. P.; Allenspach, K.; Zoldan, J.; Ben - Yakar, A. OrganoidChip facilitates hydrogel - free immobilization for fast and blur - free imaging of organoids. Sci Rep. 2023, 13, 11268.
103. Zuppinger, C. 3D cardiac cell culture: a critical review of current technologies and applications. Front Cardiovasc Med. 2019, 6, 87.
104. Strohm, E. M.; Callaghan, N. I.; Ding, Y.; Latifi, N.; Rafatian, N.; Funakoshi, S.; Fernandes, I.; Reitz, C. J.; Di Paola, M.; Gramolini, A. O.; Radisic, M.; Keller, G.; Kolios, M. C.; Simmons, C. A. Noninvasive quantification of contractile dynamics in cardiac cells, spheroids, and organs - on - a - chip using high - frequency ultrasound. ACS Nano. 2024, 18, 314 - 327.
105. Bates, R. C.; Edwards, N. S.; Yates, J. D. Spheroids and cell survival. Crit Rev Oncol Hematol. 2000, 36, 61 - 74.
106. Coutant, K.; Magne, B.; Ferland, K.; Fuentes - Rodriguez, A.; Chancy, O.; Mitchell, A.; Germain, L.; Landreville, S. Melanocytes in regenerative medicine applications and disease modeling. J Transl Med. 2024, 22, 336.
107. Arzt, M.; Pohlman, S.; Mozneb, M.; Sharma, A. Chemically defined production of tri - lineage human iPSC - derived cardiac spheroids. Curr Protoc. 2023, 3, e767.
108. Filippo Buono, M.; von Boehmer, L.; Strang, J.; Hoerstrup, S. P.; Emmert, M. Y.; Nugraha, B. Human Cardiac Organoids for Modeling Genetic Cardiomyopathy. Cells. 2020, 9, 1733.
109. Beauchamp, P.; Moritz, W.; Kelm, J. M.; Ullrich, N. D.; Agarkova, I.; Anson, B. D.; Suter, T. M.; Zuppinger, C. Development and characterization of a scaffold - free 3D spheroid model of induced pluripotent stem cell - derived human cardiomyocytes. Tissue Eng Part C Methods. 2015, 21, 852 - 861.
110. Matthys, O. B.; McDevitt, T. C. Self - assembled heterotypic cardiac spheroids from human pluripotent stem cells. Methods Mol Biol. 2022, 2485, 39 - 53.
111. Wang, Y.; Wang, N.; Chen, Y.; Yang, Y. Regulation of micropatterned curvature - dependent FA heterogeneity on cytoskeleton tension and nuclear DNA synthesis of malignant breast cancer cells. J Mater Chem B. 2022, 11, 99 - 108.
112. Wang, Y.; Wang, N.; Yang, Y.; Chen, Y.; Zhang, Z. Cellular nanomechanics derived from pattern - dependent focal adhesion and cytoskeleton to balance gene transfection of malignant osteosarcoma. J Nanobiotechnology. 2022, 20, 499.
113. Yang, Y.; Han, K.; Huang, S.; Wang, K.; Wang, Y.; Ding, S.; Zhang, L.; Zhang, M.; Xu, B.; Ma, S.; Wang, Y.; Wu, S.; Wang, X. Revelation of adhesive proteins affecting cellular contractility through reference - free traction force microscopy. J Mater Chem B. 2024, 12, 3249 - 3261.
114. Ayan, B.; Celik, N.; Zhang, Z.; Zhou, K.; Kim, M. H.; Banerjee, D.; Wu, Y.; Costanzo, F.; Ozbolat, I. T. Aspiration - assisted freeform bioprinting of prefabricated tissue spheroids in a yield - stress gel. Communications physics. 2020, 3, 183.
115. Lee, A.; Hudson, A. R.; Shiwarski, D. J.; Tashman, J. W.; Hinton, T. J.; Yerneni, S.; Bliley, J. M.; Campbell, P. G.; Feinberg, A. W. 3D bioprinting of collagen to rebuild components of the human heart. Science. 2019, 365, 482 - 487.
116. Seguret, M.; Vermersch, E.; Jouve, C.; Hulot, J. S. Cardiac organoids to model and heal heart failure and cardiomyopathies. Biomedicines. 2021, 9, 563.
117. Alonzo, M.; AnilKumar, S.; Roman, B.; Tasnim, N.; Joddar, B. 3D bioprinting of cardiac tissue and cardiac stem cell therapy. Transl Res. 2019, 211, 64 - 83.
118. Ardissino, M.; Morley, A. P.; Slob, E. A. W.; Schuermans, A.; Rayes, B.; Raisi-Estabragh, Z.; de Marvao, A.; Burgess, S.; Rogne, T.; Honigberg, M. C.; Ng, F. S. Birth weight influences cardiac structure, function, and disease risk: evidence of a causal association. Eur Heart J. 2024, 45, 443 - 454.
119. Crouch, E. E.; Diafos, L. N.; Valenzuela, E. J.; Wedderburn-Pugh, K.; Birrueta, J. O.; Caston, J.; Joseph, T.; Andrews, M. G.; Bhaduri, A.; Huang, E. J. Profiling human brain vascular cells using single - cell transcriptomics and organoids. Nat Protoc. 2024, 19, 603 - 628.
120. Li, R. A.; Keung, W.; Cashman, T. J.; Backeris, P. C.; Johnson, B. V.; Bardot, E. S.; Wong, A. O. T.; Chan, P. K. W.; Chan, C. W. Y.; Costa, K. D. Bioengineering an electro - mechanically functional miniature ventricular heart chamber from human pluripotent stem cells. Biomaterials. 2018, 163, 116 - 127.
121. Orlowska, M. K.; Krycer, J. R.; Reid, J. D.; Mills, R. J.; Doran, M. R.; Hudson, J. E. A miniaturized culture platform for control of the metabolic environment. Biomicrofluidics. 2024, 18, 024101.
122. MacQueen, L. A.; Sheehy, S. P.; Chantre, C. O.; Zimmerman, J. F.; Pasqualini, F. S.; Liu, X.; Goss, J. A.; Campbell, P. H.; Gonzalez, G. M.; Park, S. J.; Capulli, A. K.; Ferrier, J. P.; Kosar, T. F.; Mahadevan, L.; Pu, W. T.; Parker, K. K. A tissue - engineered scale model of the heart ventricle. Nat Biomed Eng. 2018, 2, 930 - 941.
123. Zhang, J. Engineered tissue patch for cardiac cell therapy. Curr Treat Options Cardiovasc Med. 2015, 17, 399.
124. Drakhlis, L.; Biswanath, S.; Farr, C. M.; Lupanow, V.; Teske, J.; Ritzenhoff, K.; Franke, A.; Manstein, F.; Bolesani, E.; Kempf, H.; Liebscher, S.; Schenke - Layland, K.; Hegermann, J.; Nolte, L.; Meyer, H.; de la Roche, J.; Thiemann, S.; Wahl - Schott, C.; Martin, U.; Zweigerdt, R. Human heart - forming organoids recapitulate early heart and foregut development. Nat Biotechnol. 2021, 39, 737 - 746.
125. Hansen, A.; Eder, A.; Bönstrup, M.; Flato, M.; Mewe, M.; Schaaf, S.; Aksehirlioglu, B.; Schwoerer, A. P.; Uebeler, J.; Eschenhagen, T. Development of a drug screening platform based on engineered heart tissue. Circ Res. 2010, 107, 35 - 44.
126. Feric, N. T.; Pallotta, I.; Singh, R.; Bogdanowicz, D. R.; Gustilo, M. M.; Chaudhary, K. W.; Willette, R. N.; Chendrimada, T. P.; Xu, X.; Graziano, M. P.; Aschar - Sobbi, R. Engineered cardiac tissues generated in the biowire II: a platform for human - based drug discovery. Toxicol Sci. 2019, 172, 89 - 97.
127. Serrao, G. W.; Turnbull, I. C.; Ancukiewicz, D.; Kim, D. E.; Kao, E.; Cashman, T. J.; Hadri, L.; Hajjar, R. J.; Costa, K. D. Myocyte - depleted engineered cardiac tissues support therapeutic potential of mesenchymal stem cells. Tissue Eng Part A. 2012, 18, 1322 - 1333.
128. Kensah, G.; Gruh, I.; Viering, J.; Schumann, H.; Dahlmann, J.; Meyer, H.; Skvorc, D.; Bär, A.; Akhyari, P.; Heisterkamp, A.; Haverich, A.; Martin, U. A novel miniaturized multimodal bioreactor for continuous in - situ assessment of bioartificial cardiac tissue during stimulation and maturation. Tissue Eng Part C Methods. 2011, 17, 463 - 473.
129. Zimmermann, W. H.; Schneiderbanger, K.; Schubert, P.; Didié, M.; Münzel, F.; Heubach, J. F.; Kostin, S.; Neuhuber, W. L.; Eschenhagen, T. Tissue engineering of a differentiated cardiac muscle construct. Circ Res. 2002, 90, 223 - 230.
130. Nattel, S. New ideas about atrial fibrillation 50 years on. Nature. 2002, 415, 219 - 226.
131. Colman, M. A. Arrhythmia mechanisms and spontaneous calcium release: Bi - directional coupling between re - entrant and focal excitation. PLoS Comput Biol. 2019, 15, e1007260.
132. Wang, Y.; Yang, Y.; Yoshitomi, T.; Kawazoe, N.; Yang, Y.; Chen, G. Regulation of gene transfection by cell size, shape and elongation on micropatterned surfaces. J Mater Chem B. 2021, 9, 4329 - 4339.
133. Wang, Y.; Yang, Y.; Wang, X.; Yoshitomi, T.; Kawazoe, N.; Yang, Y.; Chen, G. Micropattern - controlled chirality of focal adhesions regulates the cytoskeletal arrangement and gene transfection of mesenchymal stem cells. Biomaterials. 2021, 271, 120751.
134. Wang, Y.; Yang, Y.; Wang, X.; Kawazoe, N.; Yang, Y.; Chen, G. The varied influences of cell adhesion and spreading on gene transfection of mesenchymal stem cells on a micropatterned substrate. Acta Biomater. 2021, 125, 100 - 111.
135. Múnera, J. O.; Wells, J. M. Generation of gastrointestinal organoids from human pluripotent stem cells. Methods Mol Biol. 2017, 1597, 167 - 177.
136. Silva, A. C.; Matthys, O. B.; Joy, D. A.; Kauss, M. A.; Natarajan, V.; Lai, M. H.; Turaga, D.; Blair, A. P.; Alexanian, M.; Bruneau, B. G.; McDevitt, T. C. Co - emergence of cardiac and gut tissues promotes cardiomyocyte maturation within human iPSC - derived organoids. Cell Stem Cell. 2021, 28, 2137 - 2152.e6.
137. Rossi, G.; Broguiere, N.; Miyamoto, M.; Boni, A.; Guiet, R.; Girgin, M.; Kelly, R. G.; Kwon, C.; Lutolf, M. P. Capturing cardiogenesis in gastruloids. Cell Stem Cell. 2021, 28, 230 - 240.e6.
138. Shadrin, I. Y.; Allen, B. W.; Qian, Y.; Jackman, C. P.; Carlson, A. L.; Juhas, M. E.; Bursac, N. Cardiopatch platform enables maturation and scale - up of human pluripotent stem cell - derived engineered heart tissues. Nat Commun. 2017, 8, 1825.
139. Stiefbold, M.; Zhang, H.; Wan, L. Q. Engineered platforms for mimicking cardiac development and drug screening. Cell Mol Life Sci. 2024, 81, 197.
140. Jasim, S. A.; Bokov, D. O.; Suksatan, W.; Alsaikhan, F.; Jawad, M. A.; Sharma, S. K.; Chupradit, S.; Thangavelu, L. Organoid models of heart diseases: find a new channel in improvements of cardiac regenerative medicine. Curr Med Chem. 2023, 30, 2726 - 3742.
141. Kerr, C. M.; Silver, S. E.; Choi, Y. S.; Floy, M. E.; Bradshaw, A. D.; Cho, S. W.; Palecek, S. P.; Mei, Y. Decellularized heart extracellular matrix alleviates activation of hiPSC - derived cardiac fibroblasts. Bioact Mater. 2024, 31, 463 - 474.
142. Chandra Sekar, N.; Khoshmanesh, K.; Baratchi, S. Bioengineered models of cardiovascular diseases. Atherosclerosis. 2024, 393, 117565.
143. Voges, H. K.; Mills, R. J.; Elliott, D. A.; Parton, R. G.; Porrello, E. R.; Hudson, J. E. Development of a human cardiac organoid injury model reveals innate regenerative potential. Development. 2017, 144, 1118 - 1127.
144. Song, M.; Choi, D. B.; Im, J. S.; Song, Y. N.; Kim, J. H.; Lee, H.; An, J.; Kim, A.; Choi, H.; Kim, J. C.; Han, C.; Jeon, Y. K.; Kim, S. J.; Woo, D. H. Modeling acute myocardial infarction and cardiac fibrosis using human induced pluripotent stem cell - derived multi - cellular heart organoids. Cell Death Dis. 2024, 15, 308.
145. Schwach, V.; Gomes Fernandes, M.; Maas, S.; Gerhardt, S.; Tsonaka, R.; van der Weerd, L.; Passier, R.; Mummery, C. L.; Birket, M. J.; Salvatori, D. C. F. Expandable human cardiovascular progenitors from stem cells for regenerating mouse heart after myocardial infarction. Cardiovasc Res. 2020, 116, 545 - 553.
146. Gao, L.; Gregorich, Z. R.; Zhu, W.; Mattapally, S.; Oduk, Y.; Lou, X.; Kannappan, R.; Borovjagin, A. V.; Walcott, G. P.; Pollard, A. E.; Fast, V. G.; Hu, X.; Lloyd, S. G.; Ge, Y.; Zhang, J. Large cardiac muscle patches engineered from human induced - pluripotent stem cell - derived cardiac cells improve recovery from myocardial infarction in Swine. Circulation. 2018, 137, 1712 - 1730.
147. Tiburcy, M.; Hudson, J. E.; Balfanz, P.; Schlick, S.; Meyer, T.; Chang Liao, M. L.; Levent, E.; Raad, F.; Zeidler, S.; Wingender, E.; Riegler, J.; Wang, M.; Gold, J. D.; Kehat, I.; Wettwer, E.; Ravens, U.; Dierickx, P.; van Laake, L. W.; Goumans, M. J.; Khadjeh, S.; Toischer, K.; Hasenfuss, G.; Couture, L. A.; Unger, A.; Linke, W. A.; Araki, T.; Neel, B.; Keller, G.; Gepstein, L.; Wu, J. C.; Zimmermann, W. H. Defined engineered human myocardium with advanced maturation for applications in heart failure modeling and repair. Circulation. 2017, 135, 1832 - 1847.
148. Ho, B. X.; Pang, J. K. S.; Chen, Y.; Loh, Y. H.; An, O.; Yang, H. H.; Seshachalam, V. P.; Koh, J. L. Y.; Chan, W. K.; Ng, S. Y.; Soh, B. S. Robust generation of human - chambered cardiac organoids from pluripotent stem cells for improved modelling of cardiovascular diseases. Stem Cell Res Ther. 2022, 13, 529.
149. Yang, Z.; Zhang, Y.; Wang, J.; Yin, J.; Wang, Z.; Pei, R. Cardiac organoid: multiple construction approaches and potential applications. J Mater Chem B. 2023, 11, 7567 - 7581.
150. Wilke, R. A.; Lin, D. W.; Roden, D. M.; Watkins, P. B.; Flockhart, D.; Zineh, I.; Giacomini, K. M.; Krauss, R. M. Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. Nat Rev Drug Discov. 2007, 6, 904 - 916.
151. Skardal, A.; Aleman, J.; Forsythe, S.; Rajan, S.; Murphy, S.; Devarasetty, M.; Pourhabibi Zarandi, N.; Nzou, G.; Wicks, R.; Sadri - Ardekani, H.; Bishop, C.; Soker, S.; Hall, A.; Shupe, T.; Atala, A. Drug compound screening in single and integrated multi - organoid body - on - a - chip systems. Biofabrication. 2020, 12, 025017.
152. Mills, R. J.; Parker, B. L.; Quaife - Ryan, G. A.; Voges, H. K.; Needham, E. J.; Bornot, A.; Ding, M.; Andersson, H.; Polla, M.; Elliott, D. A.; Drowley, L.; Clausen, M.; Plowright, A. T.; Barrett, I. P.; Wang, Q. D.; James, D. E.; Porrello, E. R.; Hudson, J. E. Drug screening in human PSC - cardiac organoids identifies pro - proliferative compounds acting via the mevalonate pathway. Cell Stem Cell. 2019, 24, 895 - 907.e6.
153. Chen, X.; Lu, N.; Huang, S.; Zhang, Y.; Liu, Z.; Wang, X. Assessment of doxorubicin toxicity using human cardiac organoids: a novel model for evaluating drug cardiotoxicity. Chem Biol Interact. 2023, 386, 110777.
154. Palano, G.; Foinquinos, A.; Müllers, E. In vitro assays and imaging methods for drug discovery for cardiac fibrosis. Front Physiol. 2021, 12, 697270.
155. Martin, M.; Gähwiler, E. K. N.; Generali, M.; Hoerstrup, S. P.; Emmert, M. Y. Advances in 3D organoid models for stem cell - based cardiac regeneration. Int J Mol Sci. 2023, 24.
156. Davidson, S. M.; Padró, T.; Bollini, S.; Vilahur, G.; Duncker, D. J.; Evans, P. C.; Guzik, T.; Hoefer, I. E.; Waltenberger, J.; Wojta, J.; Weber, C. Progress in cardiac research: from rebooting cardiac regeneration to a complete cell atlas of the heart. Cardiovasc Res. 2021, 117, 2161 - 2174.
157. Voges, H. K.; Foster, S. R.; Reynolds, L.; Parker, B. L.; Devilée, L.; Quaife - Ryan, G. A.; Fortuna, P. R. J.; Mathieson, E.; Fitzsimmons, R.; Lor, M.; Batho, C.; Reid, J.; Pocock, M.; Friedman, C. E.; Mizikovsky, D.; Francois, M.; Palpant, N. J.; Needham, E. J.; Peralta, M.; Monte - Nieto, G. D.; Jones, L. K.; Smyth, I. M.; Mehdiabadi, N. R.; Bolk, F.; Janbandhu, V.; Yao, E.; Harvey, R. P.; Chong, J. J. H.; Elliott, D. A.; Stanley, E. G.; Wiszniak, S.; Schwarz, Q.; James, D. E.; Mills, R. J.; Porrello, E. R.; Hudson, J. E. Vascular cells improve functionality of human cardiac organoids. Cell Rep. 2023, 42, 112322.
158. Hou, J.; Chen, Y. G.; Xiong, J. W. Unveiling new horizons in heart research: the promise of multi - chamber cardiac organoids. Cell Regen. 2024, 13, 10.
159. Fan, C.; He, J.; Xu, S.; Yan, J.; Jin, L.; Dai, J.; Hu, B. Advances in biomaterial - based cardiac organoids. Biomater Adv. 2023, 153, 213502.
160. Mazzola, M.; Di Pasquale, E. Toward cardiac regeneration: combination of pluripotent stem cell - based therapies and bioengineering strategies. Front Bioeng Biotechnol. 2020, 8, 455.
161. Kastan, N. R.; Oak, S.; Liang, R.; Baxt, L.; Myers, R. W.; Ginn, J.; Liverton, N.; Huggins, D. J.; Pichardo, J.; Paul, M.; Carroll, T. S.; Nagiel, A.; Gnedeva, K.; Hudspeth, A. J. Development of an improved inhibitor of Lats kinases to promote regeneration of mammalian organs. Proc Natl Acad Sci U S A. 2022, 119, e2206113119.
162. Fernandes, I.; Funakoshi, S.; Hamidzada, H.; Epelman, S.; Keller, G. Modeling cardiac fibroblast heterogeneity from human pluripotent stem cell - derived epicardial cells. Nat Commun. 2023, 14, 8183.
163. Garg, P.; Garg, V.; Shrestha, R.; Sanguinetti, M. C.; Kamp, T. J.; Wu, J. C. Human induced pluripotent stem cell - derived cardiomyocytes as models for cardiac channelopathies: a primer for non - electrophysiologists. Circ Res. 2018, 123, 224 - 243.
164. Kim, H.; Kamm, R. D.; Vunjak - Novakovic, G.; Wu, J. C. Progress in multicellular human cardiac organoids for clinical applications. Cell Stem Cell. 2022, 29, 503 - 514.
165. Zhang, S.; Wan, Z.; Kamm, R. D. Vascularized organoids on a chip: strategies for engineering organoids with functional vasculature. Lab Chip. 2021, 21, 473 - 488.
166. Huebsch, N.; Loskill, P.; Mandegar, M. A.; Marks, N. C.; Sheehan, A. S.; Ma, Z.; Mathur, A.; Nguyen, T. N.; Yoo, J. C.; Judge, L. M.; Spencer, C. I.; Chukka, A. C.; Russell, C. R.; So, P. L.; Conklin, B. R.; Healy, K. E. Automated video - based analysis of contractility and calcium flux in human - induced pluripotent stem cell - derived cardiomyocytes cultured over different spatial scales. Tissue Eng Part C Methods. 2015, 21, 467 - 479.
167. Lin, E.; Alessio, A. What are the basic concepts of temporal, contrast, and spatial resolution in cardiac CT? J Cardiovasc Comput Tomogr. 2009, 3, 403 - 408.
168. Richards, D. J.; Li, Y.; Kerr, C. M.; Yao, J.; Beeson, G. C.; Coyle, R. C.; Chen, X.; Jia, J.; Damon, B.; Wilson, R.; Starr Hazard, E.; Hardiman, G.; Menick, D. R.; Beeson, C. C.; Yao, H.; Ye, T.; Mei, Y. Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity. Nat Biomed Eng. 2020, 4, 446 - 462.
169. Ueda, H. R.; Ertürk, A.; Chung, K.; Gradinaru, V.; Chédotal, A.; Tomancak, P.; Keller, P. J. Tissue clearing and its applications in neuroscience. Nat Rev Neurosci. 2020, 21, 61 - 79.
170. Hayes, H. B.; Nicolini, A. M.; Arrowood, C. A.; Chvatal, S. A.; Wolfson, D. W.; Cho, H. C.; Sullivan, D. D.; Chal, J.; Fermini, B.; Clements, M.; Ross, J. D.; Millard, D. C. Novel method for action potential measurements from intact cardiac monolayers with multiwell microelectrode array technology. Sci Rep. 2019, 9, 11893.
171. Gao, J.; Liao, C.; Liu, S.; Xia, T.; Jiang, G. Nanotechnology: new opportunities for the development of patch - clamps. J Nanobiotechnology. 2021, 19, 97.
172. Passaro, A. P.; Stice, S. L. Electrophysiological analysis of brain organoids: current approaches and advancements. Front Neurosci. 2020, 14, 622137.
173. Lee, J.; Sutani, A.; Kaneko, R.; Takeuchi, J.; Sasano, T.; Kohda, T.; Ihara, K.; Takahashi, K.; Yamazoe, M.; Morio, T.; Furukawa, T.; Ishino, F. In vitro generation of functional murine heart organoids via FGF4 and extracellular matrix. Nat Commun. 2020, 11, 4283.
174. Wang, Y.; Tong, X.; Shi, X.; Keswani, T.; Chatterjee, E.; Chen, L.; Li, G.; Lee, K.; Guo, T.; Yu, Y. Chiral cell nanomechanics originated in clockwise/counterclockwise biofunctional microarrays to govern the nuclear mechanotransduction of mesenchymal stem cells. ACS Appl Mater Interfaces. 2023, 15, 48038 - 48049.
175. Taegtmeyer, H.; Young, M. E.; Lopaschuk, G. D.; Abel, E. D.; Brunengraber, H.; Darley - Usmar, V.; Des Rosiers, C.; Gerszten, R.; Glatz, J. F.; Griffin, J. L.; Gropler, R. J.; Holzhuetter, H. G.; Kizer, J. R.; Lewandowski, E. D.; Malloy, C. R.; Neubauer, S.; Peterson, L. R.; Portman, M. A.; Recchia, F. A.; Van Eyk, J. E.; Wang, T. J. Assessing cardiac metabolism: a scientific statement from the American Heart Association. Circ Res. 2016, 118, 1659 - 1701.
176. Romeo, S. G.; Secco, I.; Schneider, E.; Reumiller, C. M.; Santos, C. X. C.; Zoccarato, A.; Musale, V.; Pooni, A.; Yin, X.; Theofilatos, K.; Trevelin, S. C.; Zeng, L.; Mann, G. E.; Pathak, V.; Harkin, K.; Stitt, A. W.; Medina, R. J.; Margariti, A.; Mayr, M.; Shah, A. M.; Giacca, M.; Zampetaki, A. Human blood vessel organoids reveal a critical role for CTGF in maintaining microvascular integrity. Nat Commun. 2023, 14, 5552.
177. Ferrick, D. A.; Neilson, A.; Beeson, C. Advances in measuring cellular bioenergetics using extracellular flux. Drug Discov Today. 2008, 13, 268 - 274.
178. Horikoshi, Y.; Yan, Y.; Terashvili, M.; Wells, C.; Horikoshi, H.; Fujita, S.; Bosnjak, Z. J.; Bai, X. Fatty acid - treated induced pluripotent stem cell - derived human cardiomyocytes exhibit adult cardiomyocyte - like energy metabolism phenotypes. Cells. 2019, 8, 1095.
179. Matkovich, S. J. Multiomic approaches to delineate the pathogenesis of cardiac disease. Curr Opin Cardiol. 2019, 34, 246 - 253.
180. Paik, D. T.; Chandy, M.; Wu, J. C. Patient and disease - specific induced pluripotent stem cells for discovery of personalized cardiovascular drugs and therapeutics. Pharmacol Rev. 2020, 72, 320 - 342.
181. Li, S.; Wang, Y.; Jiang, H.; Bai, Y.; Chen, T.; Chen, M.; Ma, M.; Yang, S.; Wu, Y.; Shi, C.; Wang, F.; Chen, Y. Display of CCL21 on cancer cell membrane through genetic modification using a pH low insertion peptide. Int J Biol Macromol. 2023, 240, 124324.
182. Ramilowski, J. A.; Goldberg, T.; Harshbarger, J.; Kloppmann, E.; Lizio, M.; Satagopam, V. P.; Itoh, M.; Kawaji, H.; Carninci, P.; Rost, B.; Forrest, A. R. A draft network of ligand - receptor - mediated multicellular signalling in human. Nat Commun. 2015, 6, 7866.
183. Packer, J.; Trapnell, C. Single - cell multi - omics: an engine for new quantitative models of gene regulation. Trends Genet. 2018, 34, 653 - 665.
184. Asp, M.; Giacomello, S.; Larsson, L.; Wu, C.; Fürth, D.; Qian, X.; Wärdell, E.; Custodio, J.; Reimegård, J.; Salmén, F.; Österholm, C.; Ståhl, P. L.; Sundström, E.; Åkesson, E.; Bergmann, O.; Bienko, M.; Månsson - Broberg, A.; Nilsson, M.; Sylvén, C.; Lundeberg, J. A spatiotemporal organ - wide gene expression and cell atlas of the developing human heart. Cell. 2019, 179, 1647 - 1660.e19.
185. Mantri, M.; Scuderi, G. J.; Abedini - Nassab, R.; Wang, M. F. Z.; McKellar, D.; Shi, H.; Grodner, B.; Butcher, J. T.; De Vlaminck, I. Spatiotemporal single - cell RNA sequencing of developing chicken hearts identifies interplay between cellular differentiation and morphogenesis. Nat Commun. 2021, 12, 1771.